Jonathan Allan, General Counsel & Corporate Secretary at Stoke Therapeutics, Inc. (STOK), sold 1,948 shares at $13.48 ($26K) on 2023-06-21, disclosed to the SEC on 2023-06-23.
Scheduled sale ($26k) by General Counsel & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| STOK | SELL | 2026-06-18 | $44K | — | Filing → |
| STOK | SELL | 2026-03-24 | $626K | — | Filing → |
| STOK | SELL | 2026-03-19 | $569K | — | Filing → |